Immune-Mediated Complications during Interferon Therapy in Hematological Patients

Publisher： Karger

E-ISSN： 1421-9662|107|3|133-144

ISSN： 0001-5792

Source： Acta Haematologica, Vol.107, Iss.3, 2002-04, pp. : 133-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tuberculosis screening prior to anti‐tumor necrosis factor therapy among patients with immune‐mediated inflammatory diseases in Japan: a longitudinal study using a large‐scale health insurance claims database

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 20, Iss. 11, 2017-11 ,pp. : 1674-1683

John Wiley & Sons Inc

Access to resources Recommend Favorite

Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001–2002

By Robinson Don   Hackett Monica   Wong John   Kimball Alexa B.   Cohen Russell   Bala Mohan    

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 989-1000

Informa Healthcare

Access to resources Recommend Favorite

Infection and Malignancy Risk in Patients Treated with TNF Inhibitors for Immune-Mediated Inflammatory Diseases

By  

Current Drug Safety, Vol. 12, Iss. 3, 2017-10 ,pp. : 162-170

Bentham Science Publishers

Access to resources Recommend Favorite

Acute and chronic immune biomarker changes during interferon/ribavirin treatment in HIV/HCV co‐infected patients

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 1, 2015-01 ,pp. : 25-36

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hematuria due to Immune-Mediated Thrombocytopenic Purpura

By  

Urologia Internationalis, Vol. 67, Iss. 1, 2001-07 ,pp. : 80-81

Karger

Access to resources Recommend Favorite